UNLABELLED: The impact of salivary flow reduction following medication (scopolamine and botulinum neurotoxin) on social interaction and emotional development (self-esteem) was evaluated in a group of 45 children with cerebral palsy who suffered from severe drooling. The children ranged in age from 3 to 16 years (median 9.1 years); 28 were male, 17 female. A questionnaire to document the impact of drooling on social interaction and self-esteem for both the children and their parents was developed and administered during the use of scopolamine and up to 24 weeks after intraglandular botulinum neurotoxin in the submandibular glands. The reduction of drooling was related to increased social contacts with peers. In addition, parents perceived that the impact of drooling on the level of the child's satisfaction on physical appearance, relations within the extended family, and life in general increased. Although medication led to (temporary) positive changes, many social and emotional consequences remained unchanged. CONCLUSION: Interventions to treat drooling should not only be evaluated using measurements of drooling, but the consequences on social interaction and self-esteem should also be assessed.
UNLABELLED: The impact of salivary flow reduction following medication (scopolamine and botulinum neurotoxin) on social interaction and emotional development (self-esteem) was evaluated in a group of 45 children with cerebral palsy who suffered from severe drooling. The children ranged in age from 3 to 16 years (median 9.1 years); 28 were male, 17 female. A questionnaire to document the impact of drooling on social interaction and self-esteem for both the children and their parents was developed and administered during the use of scopolamine and up to 24 weeks after intraglandular botulinum neurotoxin in the submandibular glands. The reduction of drooling was related to increased social contacts with peers. In addition, parents perceived that the impact of drooling on the level of the child's satisfaction on physical appearance, relations within the extended family, and life in general increased. Although medication led to (temporary) positive changes, many social and emotional consequences remained unchanged. CONCLUSION: Interventions to treat drooling should not only be evaluated using measurements of drooling, but the consequences on social interaction and self-esteem should also be assessed.
Authors: P H Jongerius; J J Rotteveel; F van den Hoogen; F Joosten; K van Hulst; F J Gabreëls Journal: Eur J Pediatr Date: 2001-08 Impact factor: 3.183
Authors: Sung Hwa Ko; Yong Beom Shin; Ji Hong Min; Myung Jun Shin; Jae Hyeok Chang; Yong-Il Shin; Hyun-Yoon Ko Journal: Ann Rehabil Med Date: 2013-12-23
Authors: Kristie L Bell; Roslyn N Boyd; Sean M Tweedy; Kelly A Weir; Richard D Stevenson; Peter S W Davies Journal: BMC Public Health Date: 2010-04-06 Impact factor: 3.295
Authors: Karen Van Hulst; Jan Jw Van Der Burg; Peter H Jongerius; Alexander Ch Geurts; Corrie E Erasmus Journal: Dev Med Child Neurol Date: 2019-11-14 Impact factor: 5.449
Authors: Jeremy R Parr; Emma Todhunter; Lindsay Pennington; Deborah Stocken; Jill Cadwgan; Anne E O'Hare; Catherine Tuffrey; Jane Williams; Mike Cole; Allan F Colver Journal: Arch Dis Child Date: 2017-11-30 Impact factor: 3.791
Authors: Emanuele F Russo; Rocco S Calabrò; Patrizio Sale; Filomena Vergura; Maria C De Cola; Angela Militi; Placido Bramanti; Simona Portaro; Serena Filoni Journal: Int J Med Sci Date: 2019-09-20 Impact factor: 3.738